|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/46 | |
| A61K 9/12 | |||
| A61P 25/22 | |||
| A61P 25/24 |
| (11) | Number of the document | 1896025 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06760136.9 |
| Date of filing the European patent application | 2006-05-18 | |
| (97) | Date of publication of the European application | 2008-03-12 |
| (45) | Date of publication and mention of the grant of the patent | 2011-12-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/019335 |
| Date | 2006-05-18 |
| (87) | Number | WO 2006/127418 |
| Date | 2006-11-30 |
| (30) | Number | Date | Country code |
| 137114 | 2005-05-25 | US |
| (72) |
FUREY, Maura, L., US
DREVETS, Wayne, C., US
|
| (73) |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES,
Office of Technology Transfer, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852-3804,
US
|
| (54) | SCOPOLAMINE FOR THE TREATMENT OF DEPRESSION AND ANXIETY |
| SCOPOLAMINE FOR THE TREATMENT OF DEPRESSION AND ANXIETY |